Fda Commissioner Margaret

Anti-addiction formulation of super-strong opioid unclear

Anti-addiction formulation of super-strong opioid unclear

By Fiona Barry

Addiction doctors have petitioned the US FDA to prevent Zohydro ER, the first single-entity hydrocodone painkiller, hitting the market this month citing its potential for abuse. Its maker, Zogenix, has been tight-lipped on whether the drug’s formulation...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers